Stephen Aselage
Senior Advisor

Stephen Aselage is a Senior Advisor to IntraBio Inc. Mr. Aselage most recently served as Chief Executive Officer of Travere Therapeutics, a biopharmaceutical company specializing in identifying, developing, and delivering life-changing therapies to people living with rare diseases, which he joined in 2012. He has more than 40 years of experience in the biopharmaceutical industry, including substantial rare disease, commercial, and business development experience.

From 2005 to 2012, Mr. Aselage served as Executive Vice President and Chief Business Officer of BioMarin. Prior to BioMarin, Mr. Aselage held positions of increasing responsibility at a number of companies, including Bristol Laboratories, Genentech, and Sangstat. He served as the chairman of Acer and on the board of Travere.

He currently serves as chairman of Acuitas, as Director at BioCryst Pharmaceuticals, and on the advisory council of the University of Notre Dame Department of Science.

Privacy Policy Cookies Policy ©2024 IntraBio. All rights reserved.